BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30033446)

  • 1. Routine blood investigations have limited utility in surveillance of aggressive lymphoma in asymptomatic patients in complete remission.
    Hawkes EA; Loh Z; Estacio O; Chong G; Ha FJ; Gilbertson M; Grigg A
    Br J Cancer; 2018 Aug; 119(5):546-550. PubMed ID: 30033446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited utility of surveillance imaging for detecting disease relapse in patients with non-Hodgkin lymphoma in first complete remission.
    Truong Q; Shah N; Knestrick M; Curley B; Hu Y; Craig M; Hamadani M
    Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):50-5. PubMed ID: 24119465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of Routine Surveillance Laboratory Testing in Detecting Relapse in Patients With Classic Hodgkin Lymphoma in First Remission: Results From a Large Single-Institution Study.
    Lynch RC; Sundaram V; Desai M; Henry S; Wood D; Daadi S; Hoppe RT; Advani R
    JCO Oncol Pract; 2020 Sep; 16(9):e902-e911. PubMed ID: 32369413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine Blood Tests in Asymptomatic Patients With Indolent Lymphoma Have Limited Ability to Detect Clinically Significant Disease Progression.
    Piercey OA; Loh Z; Chan J; Chong G; Grigg A; Cheema S; Gill G; Whybird M; Cushion T; Hawkes EA
    JCO Oncol Pract; 2020 Nov; 16(11):e1315-e1323. PubMed ID: 32584701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma.
    El-Galaly TC; Mylam KJ; Bøgsted M; Brown P; Rossing M; Gang AO; Haglund A; Arboe B; Clausen MR; Jensen P; Pedersen M; Bukh A; Jensen BA; Poulsen CB; d'Amore F; Hutchings M
    Am J Hematol; 2014 Jun; 89(6):575-80. PubMed ID: 24493389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Surveillance Imaging in Patients With Peripheral T-Cell Lymphoma.
    Tang T; Chen Z; Praditsuktavorn P; Khoo LP; Ruan J; Lim ST; Tan D; Phipps C; Lee YS; Goh YT; Hwang W; Tao M; Quek R; Farid M; Furman RR; Leonard JP; Martin P
    Clin Lymphoma Myeloma Leuk; 2016 Mar; 16(3):117-21. PubMed ID: 26796979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routine Imaging for Diffuse Large B-Cell Lymphoma in First Complete Remission Does Not Improve Post-Treatment Survival: A Danish-Swedish Population-Based Study.
    El-Galaly TC; Jakobsen LH; Hutchings M; de Nully Brown P; Nilsson-Ehle H; Székely E; Mylam KJ; Hjalmar V; Johnsen HE; Bøgsted M; Jerkeman M
    J Clin Oncol; 2015 Dec; 33(34):3993-8. PubMed ID: 26438115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited clinical benefit for surveillance PET-CT scanning in patients with histologically transformed lymphoma in complete metabolic remission following primary therapy.
    Cheah CY; Dickinson M; Hofman MS; George A; Ritchie DS; Prince HM; Westerman D; Harrison SJ; Burbury K; Wolf M; Januszewicz H; Herbert KE; Carney DA; Tam C; Seymour JF
    Ann Hematol; 2014 Jul; 93(7):1193-200. PubMed ID: 24595733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of follow-up procedures in patients with large-cell lymphoma who achieve a complete remission.
    Weeks JC; Yeap BY; Canellos GP; Shipp MA
    J Clin Oncol; 1991 Jul; 9(7):1196-203. PubMed ID: 1710656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated lactate dehydrogenase levels detected during routine follow-up do not predict relapse in patients with diffuse large B-cell lymphoma who achieve complete remission after primary treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone-like immunochemotherapy.
    El-Sharkawi D; Basu S; Ocampo C; Qian W; D'Sa S; Hoskin PJ; Ardeshna KM
    Leuk Lymphoma; 2012 Oct; 53(10):1949-52. PubMed ID: 22462615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Routine Surveillance Imaging on the Outcomes of Patients With Classical Hodgkin Lymphoma After Autologous Hematopoietic Cell Transplantation.
    Kapke JT; Epperla N; Shah N; Richardson K; Carrum G; Hari PN; Pingali SR; Hamadani M; Karmali R; Fenske TS
    Clin Lymphoma Myeloma Leuk; 2017 Jul; 17(7):408-414. PubMed ID: 28756899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced-stage Hodgkin lymphoma: US/chest radiography for detection of relapse in patients in first complete remission--a randomized trial of routine surveillance imaging procedures.
    Picardi M; Pugliese N; Cirillo M; Zeppa P; Cozzolino I; Ciancia G; Pettinato G; Salvatore C; Quintarelli C; Pane F
    Radiology; 2014 Jul; 272(1):262-74. PubMed ID: 24708193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphoma.
    Hill M; Cunningham D; MacVicar D; Roldan A; Husband J; McCready R; Mansi J; Milan S; Hickish T
    J Clin Oncol; 1993 Nov; 11(11):2273-8. PubMed ID: 8229142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of relapse in non-Hodgkin's lymphoma: role of routine follow-up studies.
    Elis A; Blickstein D; Klein O; Eliav-Ronen R; Manor Y; Lishner M
    Am J Hematol; 2002 Jan; 69(1):41-4. PubMed ID: 11835330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of 18F-FDG coincidence SPECT imaging and computed tomography in the initial staging and therapeutic evaluation of lymphomas].
    Qiao WL; Zhao JH; Wang C; He ZY; Wang TS; Xing Y
    Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):536-9. PubMed ID: 18069637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of surveillance studies for patients with stage I to II diffuse large B-cell lymphoma in the rituximab era.
    Hiniker SM; Pollom EL; Khodadoust MS; Kozak MM; Xu G; Quon A; Advani RH; Hoppe RT
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):99-106. PubMed ID: 25863757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited utility of routine surveillance imaging for classical Hodgkin lymphoma patients in first complete remission.
    Pingali SR; Jewell SW; Havlat L; Bast MA; Thompson JR; Eastwood DC; Bartlett NL; Armitage JO; Wagner-Johnston ND; Vose JM; Fenske TS
    Cancer; 2014 Jul; 120(14):2122-9. PubMed ID: 24711253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of surveillance computed tomography in the follow-up of diffuse large B-cell and follicular lymphomas.
    Lin TL; Kuo MC; Shih LY; Dunn P; Wang PN; Wu JH; Tang TC; Chang H; Hung YS; Lu SC
    Ann Hematol; 2012 Nov; 91(11):1741-5. PubMed ID: 22729139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of usefulness of computed tomography for surveillance in patients with aggressive non-Hodgkin lymphoma.
    Kang KW; Lee SR; Kim DS; Yu ES; Sung HJ; Kim SJ; Choi CW; Park Y; Kim BS
    PLoS One; 2018; 13(2):e0192656. PubMed ID: 29444176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.